Newswise — FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®), an alliance of the nation’s leading cancer centers dedicated to quality, effectiveness, and efficiency of cancer care, today announced that University of Wisconsin Carbone Cancer Center has been elected to institutional membership. NCCN now has 27 Member Institutions serving the needs of people with cancer throughout the United States.
“We are pleased to welcome University of Wisconsin Carbone Cancer Center as an NCCN Member Institution,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “UWCCC’s esteemed cancer center indeed brings unique attributes to the alliance, particularly its comprehensive palliative care program which includes an in-patient unit and consultation service, children’s hospital consultative service, and an outpatient onco-palliative care clinic.”
“Our collaboration with University of Wisconsin Carbone Cancer Center will play an integral role as NCCN strengthens its foothold in national oncology policy,” said Gary J. Weyhmuller, MBA, SPHR, Executive Vice President/Chief Operating Officer, NCCN. “As part of its impressive policy program, UWCCC houses a coalition of more than 100 organizations in Wisconsin working to reduce the burden of cancer by convening governmental affairs experts, cancer care providers, and health care administrators.”
An integral part of the University of Wisconsin School of Medicine and Public Health, the University of Wisconsin Carbone Cancer Center unites more than 280 physicians and scientists who work together in translating discoveries from research laboratories into new treatments that benefit people with cancer. The only National Cancer Institute (NCI)-designated comprehensive cancer center in Wisconsin, the University of Wisconsin Carbone Cancer Center provides the best available cancer care to more than 31,000 patients each year and participates in more than 250 clinical trials annually.
"As one of the original NCI-designated comprehensive cancer centers, we are delighted to have the opportunity to join the esteemed cancer centers of NCCN, which share our devotion to improving the lives of people with cancer through the rapid application of cancer discovery to cancer care and education," said Howard Bailey, MD, Director of the UW Carbone Cancer Center.
As an NCCN Member Institution, expert faculty from University of Wisconsin Carbone Cancer Center will have the opportunity to represent their institution on the 49 multidisciplinary NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panels that set the standard of cancer care and oncology policy in the United States. Additionally, University of Wisconsin Carbone Cancer Center investigators and patients will have the opportunity to participate in ground-breaking clinical trials offered through the NCCN Oncology Research Program (ORP).
Originally announced as an alliance of 13 leading cancer centers in 1995, NCCN is devoted to patient care, research, and education in order to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.
For more information about NCCN, NCCN Member Institutions, and NCCN Guidelines, visit NCCN.org.
About the National Comprehensive Cancer NetworkThe National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the nation’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.